Chemical industry in Hungary

Projects in Hungary

chemXplore tracks 41 projects in Hungary, of which 8 are active.

6 Under Construction 2 Commissioning & Start-up

6 new construction, 1 expansion, and 1 revamp / retrofit.

Expected to start operating
2026
none
2027
2 projects
2028
1 project
2029
none
2030
none
2031
none

1 of the active projects carry no start-up date yet.

What moved recently
  • 22 September 2026 MOL Danube Refinery AV3 Unit Reconstruction, Százhalombatta · Commissioning & Start-up
  • 22 September 2026 CATL Debrecen Battery Cell and Module Plant · Commissioning & Start-up
  • 17 September 2026 MOL Group Algyő Solar Park and Battery Storage · Operational / Completed
  • September 2026 MOL Százhalombatta Maleic Anhydride Expansion, Danube Refinery · Under Construction
  • June 2026 EcoPro BM Debrecen Cathode plant Phase 1 · Operational / Completed

Owners and developers: MOL Petrochemicals (3), MOL Plc (2), Contemporary Amperex Technology Co. Limited - CATL (1), GreenPower Energy Debrecen Kft. (1), LG Chem (1), LG Magna e-Powertrain (1)

Investors: MOL Plc (2)

Contractors, licensors, and offtakers are recorded on 5 of these 8 projects For subscribers

Targeting: Crude oil (1), Isobutene (1), Maleic anhydride (1), Propylene (1), plastic recycling, pyrolized, hydrocarbon liquid fraction (1)

Follow these projects in chemXplore →

Latest Hungarian chemical industry news

1 October 2026
MOL secures OFAC license to continue NIS acquisition talks

License extends negotiations to pursue a majority stake in Serbia's national oil firm through 30 Oct 2026.

27 September 2026
MOL Group Chemicals doubles maleic anhydride capacity at Százhalombatta

New unit at Danube Refinery will double maleic anhydride output and is due online in H2 2027, aiming to strengthen European supply security and improve energy efficiency.

24 September 2026
Lilly's Onswik approved by FDA as once‑weekly basal insulin for adults with type 2 diabetes

FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.

22 September 2026
CATL Debrecen starts trial production in new cell building

Trial operations began 22 Sept 2026 in the new Debrecen cell factory, activating the first two production lines after occupancy and IPPC preconditions were met.

22 September 2026
MOL completes reconstruction of AV3 unit at Danube Refinery

Fire-damaged crude distillation unit rebuilt with an 18 billion‑forint repair budget; phased restart and safety testing will begin, with production returning in October.

18 September 2026
EMA CHMP restricts and redefines ipidacrine indications

CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.

17 September 2026
MOL Group opens 37.4 MWp solar park and 40 MWh battery at Algyő

37.4 MWp solar park and 20 MW/40 MWh battery at Algyő boost on-site energy independence and cut ~13,000 tCO2/yr.

17 September 2026
EASA: EU SAF supply surpasses 2025 ReFuelEU target

SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.

7 August 2026
MOL Group Q2 2026 results

Q2 profit USD 786m; strong oil and gas prices plus higher refining and petrochemical margins offset fuel price caps and operational outages.

24 July 2026
MOL Group launches court challenge to Hungary CO2 quota tax

Seeks refund after Tax Authority rejection; challenges follow EU court ruling that the tax breaches directives. Dispute valued at HUF 126.0 billion (~USD 395m).

Chemical parks and clusters

active / all projects